MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: ZOLL Medical Corporation
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

ZOLL Files with Japan's Pharmaceuticals and Medical Devices Agency for New Indication for Intravascular Temperature Management Technology - Approval Sought to Use Temperature Management for Sudden Cardiac Arrest - ZOLL.com
ZOLL Files with Japan's Pharmaceuticals and Medical Devices Agency for New Indication for Intravascular Temperature Management Technology

 

NewswireToday - /newswire/ - Chelmsford, MA, United States, 2014/11/24 - Approval Sought to Use Temperature Management for Sudden Cardiac Arrest - ZOLL.com. NASDAQ: ZOLL

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that its Japanese subsidiary, Asahi Kasei ZOLL Medical Corp. (AZM), has filed an application with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for approval for the company’s Intravascular Temperature Management (IVTM™) System to be used for sudden cardiac arrest.

AZM conducted a clinical study in Japan from January 2013 to February 2014 for the indication of temperature management after resuscitation from cardiac arrest. The application for the new indication was filed based on the results of this study following consultation and advice from the PMDA. The application also includes approval for ZOLL’s Quattro™ and Icy® as new catheters for use in temperature management. Currently, only the Cool Line® catheter has approval.

“Use of temperature management for sudden cardiac arrest is recommended in numerous national guidelines including the Japan Resuscitation Council Guidelines 2010, which we think will be informative in the PMDA’s consideration of our application,” said James A. Palazzolo, President of ZOLL. “In treating resuscitated patients, there is a need for easy-to-use equipment that enables precise cooling and rewarming of core body temperature. By expanding indications for IVTM in Japan, AZM seeks to contribute to advance technology for resuscitation therapy.”

ZOLL’s IVTM system provides cooling and warming through a balloon catheter inserted into the venous system. This provides precise control of the core body temperature over surface methods by directly cooling or warming the patient’s blood as it flows through the body. This catheter is connected to the Thermogard XP® console, which circulates cold saline solution inside the catheter. Since the saline flows only within the catheter, no fluid is infused into the patient. ZOLL offers a variety of triple-lumen catheters with placement options to handle specific patient challenges. The ZOLL IVTM system is precise, efficient, and easy to use, and frees up clinical staff to attend to other patient needs. No product has been specifically approved in the U.S. for cardiac arrest.

About ZOLL Medical Corporation
ZOLL Medical Corporation (zoll.com), an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care.

About Asahi Kasei
The Asahi Kasei Group (asahi-kasei.co.jp) is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 29,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries.

Copyright © 2014 ZOLL Medical Corporation. All rights reserved. Cool Line, Icy, Quattro, Thermogard XP, and ZOLL are trademarks and/or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All trademarks are the property of their respective owners.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: ZOLL Medical Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


ZOLL Files with Japan's Pharmaceuticals and Medical Devices Agency for New Indication for Intravascular Temperature Management Technology

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Diane Egan - ZOLL.com 
978-421-9637 degan[.]zoll.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any ZOLL Medical Corporation securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From ZOLL Medical Corporation / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Bruker Introduces Updated B.I.QUANT-UR™ Module for Fully Validated Metabolite Quantification in Urine Using NMR
SCHOTT Extends SyriQ BioPure® Syringe Format to Enable Optimized Administration
Hand Hygiene Market Will Reach .98 Billion in the US and EU5 with High Adoption of Gamification Finds Frost & Sullivan
Rise in Pharmaceutical Applications to Foster Demand for Mass Spectrometers in Europe Finds Frost & Sullivan
Cala Health Applauded by Frost & Sullivan for Revolutionizing the Essential Tremor Market with its Body-worn Neuromodulation Therapy, Cala Trio™
Withings Launches ScanWatch - the First Hybrid Smartwatch to Combine Medical Grade Electrocardiogram and Sleep Apnea Detection
Bruker Introduces Dedicated Light-Sheet Microscope for Highly Multiplexed 3D Cell Culture Live Imaging
Inkwood Research Publishes Global 3D Cell Culture Market Forecast 2019-2027
Bruker’s PeakForce Tapping is Fastest Growing AFM Mode
Philips Commended by Frost & Sullivan for Advancing Access to Affordable, High-quality Care through Its Incisive CT Platform
ZOLL to Showcase Portfolio of Advanced Resuscitation Technologies for the Workplace At A+A Congress 2019
Bruker Launches Ultrafast FTIR Imaging Microscope LUMOS II
Drug Delivery Devices Offering Enhanced Connectivity to Find Higher Uptake Among Hospitals finds Frost & Sullivan
Global Inorganic Scintillators Market Projected to Grow At 5.28% CAGR Through 2027 Reports Inkwood Research
Rising Aging Population Projects the Global Hearing Aids Market At 5.42% CAGR by 2027 Reports Inkwood Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Limelon Advertising, Co.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)